J05AG Non-nucleoside reverse transcriptase inhibitors
ATC group of level 4 – chemical subgroup · in plain English: medicines against viruses, e.g. HIV or hepatitis
This site has the patient leaflet or the SPC of 32 medicines in this group and its subgroups.
- 23 prescription only (POM)
- 8 no longer supplied or not available
Place in the ATC classification
- J Antiinfectives for systemic use 1,393 medicines
- J05 Antivirals for systemic use 392 medicines
- J05A Direct acting antivirals 392 medicines
-
J05AG Non-nucleoside reverse transcriptase inhibitors 32 medicines
- J05AG01 nevirapine 13 medicines
- J05AG03 efavirenz 9 medicines
- J05AG04 etravirine 3 medicines
- J05AG05 rilpivirine 6 medicines
- J05AG06 doravirine 1 medicine
-
J05AG Non-nucleoside reverse transcriptase inhibitors 32 medicines
- J05A Direct acting antivirals 392 medicines
- J05 Antivirals for systemic use 392 medicines
1 more subgroup has no medicine with a leaflet on this site.
Active substances in the group
- Doravirine 1 medicine
- Efavirenz 9 medicines
- Etravirine 3 medicines
- Nevirapine 13 medicines
- Rilpivirine 6 medicines
Medicines in the group and its subgroups
Other groups of the same level
- J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors 40 medicines
- J05AD Phosphonic acid derivatives, direct acting antivirals 2 medicines
- J05AE Protease inhibitors, direct acting antivirals 75 medicines
- J05AF Nucleoside and nucleotide reverse transcriptase inhibitors 82 medicines
- J05AH Neuraminidase inhibitors, direct acting antivirals 14 medicines
- J05AJ Integrase Inhibitors, antiinfectives for systematic use 15 medicines
- J05AP Antivirals for treatment of HCV infections 25 medicines
- J05AR Antivirals for treatment of HIV infections, combinations 80 medicines
- J05AX Other antivirals 27 medicines
Other names of the ATC group
- Czech: J05AG Nenukleosidové inhibitory reverzní transkriptázy
- French: J05AG inhibiteurs de la transcriptase reverse non nucléosidiques
- German: J05AG Nicht-Nukleosidale Inhibitoren der Reversen Transkriptase
- German: J05AG Nicht-Nukleosidale Inhibitoren der Reversen Transkriptase
- Italian: J05AG NON-NUCLEOSIDI INIBITORI DELLA TRANSCRITTASI INVERSA
- Polish: J05AG Nienukleozydowe inhibitory odwrotnej transkryptazy
- Turkish: J05AG Nükleozid olmayan ters transkriptaz inhibitörleri
- Portuguese (Brazil): J05AG Não-nucleosídeos, inibidores da transcriptase reversa
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group J05AG
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.